Pharmaceutical

AbbVie and Umoja to develop new CAR-T therapies for cancer

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

Jan 5, 2024 - 18:00
AbbVie and Umoja to develop new CAR-T therapies for cancer
AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.
Read the original article

Tags:

Previous Article

MOMA Therapeutics and Roche sign cancer drug discovery deal

Next Article

Pharmaceutical Technology Excellence Awards 2023: KAI Conversations

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Oncternal stock crashes by 60% as it lays off staff and scraps trials

Oncternal stock crashes by 60% as it lays off staff and...

Sep 14, 2024

AC Immune wins FDA fast track for Alzheimer’s vaccine candidate

AC Immune wins FDA fast track for Alzheimer’s vaccine c...

Jul 26, 2024

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio ...

Oct 26, 2024